Drug – bio-affecting and body treating compositions – Enzyme or coenzyme containing – Hydrolases
Patent
1997-07-09
1999-09-21
Hendricks, Keith D.
Drug, bio-affecting and body treating compositions
Enzyme or coenzyme containing
Hydrolases
4241831, 435199, 435 697, 530350, 5303917, 536 232, 536 234, A61K 3846, C12N 1554, C12N 1562
Patent
active
059550732
ABSTRACT:
The present invention relates to a selective cytotoxic RNase reagent. The reagent comprises a toxic moiety that is an RNase linked to a recognition moiety that binds a specific cell surface marker. Binding of the recognition moiety to a surface marker on a cell allows the toxic moiety to selectively kill the cell. To reduce immunogenicity, preferably the toxic moiety and the recognition moiety of the conjugate are endogenous to the species in which the reagent is intended for use. Cytotoxic reagents intended for use in humans preferably have as the toxic moiety a human ribonuclease, such as angiogenin, and as the recognition moiety as humanized chimeric antibody. The human ribonuclease and chimeric antibody preferably form a fused protein. The present invention also relates to pharmaceutical compositions including the cytotoxic reagent as well as treatment methods involving the use of the cytotoxic reagent.
REFERENCES:
Ardelt et al., J. Biol Chem. 256:245-251 (1991).
Beintema et al., Biochem. 27:4530-38 (1988).
Blank et al., Human body fluid ribonucleases: detection, interrelationships and significance 1:203-209 (ILR Press, London 1981).
Carlsson et al., Biochem. 173:723-737 (1978).
DeGraaf et al., Eur. J. Biochem. 73:107-114 (1977).
Endo et al., J. Biol. Chem., 257:9054-9060 (1982).
Endo et al., J. Biol Chem. 258:2662-2667 (1983).
Endo et al., J. Biol Chem. 262:8128-8130 (1987).
Fett et al., Biochem. 24:5480-5485 (1985).
FitzGerald et al., Proc. Natl. Acad. Sci. USA 80:4134 (1983).
FitzGerald et al., Cancer Res. 47:1407-1410 (1987).
Gleich et al., Proc. Natl. Acad. Sci. USA 83:3146-3150 (1986).
Glukhov et al., Arch. Neurol. 38:398-603 (1976).
Gullberg et al., Biophys. Biochem. Res. Comm. 139(3):1239-1242 (1986).
Hoogenboom et al., J. Immunol. 144(8):3211-3217 (1990).
Johnson et al., J. Biol. Chem. 263:1295-1300 (1988).
Konisky, J., Rev. Microbiol. 36:125-144 (1982).
Kurachi et al., Biochemistry 24:1594-1599 (1985).
Leone et al., J. Reprod., Fert. 34:197-200 (1973).
MacGillivray et al., Proc. Natl. Acad. Sci. USA 79:2504-2408 (1982).
Marks et al., Cancer Res. 50:288-292 (1990).
Matousek, J., Experientia 29:858-859 (1973).
Moolten et al., Immunol. Rev. 62:47-73 (1982).
Nambiar et al., Eur J. Biochem. 163:67-71 (1987).
O'Keefe et al., J. Biol. Chem. 260(2):932-937 (1985).
Pirker et al. Cancer Res. 45:751-757 (1985).
Prior et al., Cell 64:1017-1023 (1991).
Raso et al., J. Biol. Chem. 259(2):1143-1149 (1984).
Reddi, E., Biochem. Biophys. Res. Commun. 67:110-118 (1975).
Roth, J., Cancer Res. 23:657-666 (1963).
Rybak et al., Biochem. 25:3527-3531 (1988).
Rybak et al., "Human Cancer Immunology" in Immunology & Allergy Clinics of America (1990).
St. Clair et al., Proc. Natl. Acad. Sci. USA 94:8330-8334 (1987).
St. Clair et al., Biochem. 27:7263-7268 (1988).
Scott et al., J. Natl. Cancer Inst. 79(5):1163-1172 (1987).
Shapiro et al., Biochem. 26:5141-5146 (1987).
Slifman et al., J. Immunol. 137(9):2913-2917 (1988).
Trowbridge et al., Nature 294:171-173 (1981).
Vescia et al., Cancer Res. 40:3740-3744 (1980).
Youle et al., Immunoconjuncates: Antibody Conjugates in Radioimaging and Therapy of Cancer. Oxford, Oxford University Press (1987).
Rybak et al., J. Biol Chem., vol. 266, No. 31, Nov. 5, 1991, pp. 21202-21207.
Newton Dianne L.
Nicholls Peter J.
Rybak Susanna M.
Youle Richard J.
Hendricks Keith D.
The United States of America as represented by the Department of
LandOfFree
Selective RNase cytotoxic reagents does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Selective RNase cytotoxic reagents, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Selective RNase cytotoxic reagents will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-77532